Search details
1.
Establishment of a prognostic model to predict chemotherapy response and identification of RAC3 as a chemotherapeutic target in bladder cancer.
Environ Toxicol
; 39(2): 509-528, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37310098
2.
A clinically practical model for the preoperative prediction of lymph node metastasis in bladder cancer: a multicohort study.
Br J Cancer
; 129(7): 1166-1175, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37542107
3.
NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR.
Mol Ther
; 29(1): 291-307, 2021 01 06.
Article
in English
| MEDLINE | ID: mdl-32950106
4.
UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer.
Cell Death Dis
; 14(7): 408, 2023 07 08.
Article
in English
| MEDLINE | ID: mdl-37422473
5.
SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway.
Cancer Med
; 12(12): 13471-13485, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37119046
6.
TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination.
J Exp Clin Cancer Res
; 42(1): 195, 2023 Aug 05.
Article
in English
| MEDLINE | ID: mdl-37542345
7.
Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer.
Front Oncol
; 12: 957404, 2022.
Article
in English
| MEDLINE | ID: mdl-36119488
8.
Bibliometric analysis of the global research development of bone metastases in prostate cancer: A 22-year study.
Front Oncol
; 12: 947445, 2022.
Article
in English
| MEDLINE | ID: mdl-36237319
9.
UBE2S as a novel ubiquitinated regulator of p16 and ß-catenin to promote bone metastasis of prostate cancer.
Int J Biol Sci
; 18(8): 3528-3543, 2022.
Article
in English
| MEDLINE | ID: mdl-35637955
10.
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program.
Cancer Commun (Lond)
; 42(5): 447-470, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35434944
11.
Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.
J Exp Clin Cancer Res
; 40(1): 203, 2021 Jun 21.
Article
in English
| MEDLINE | ID: mdl-34154613
12.
WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer.
Theranostics
; 11(10): 4809-4824, 2021.
Article
in English
| MEDLINE | ID: mdl-33754029
13.
HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma.
J Immunother Cancer
; 8(1)2020 01.
Article
in English
| MEDLINE | ID: mdl-31959726
14.
Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer.
Cancer Manag Res
; 11: 1517-1524, 2019.
Article
in English
| MEDLINE | ID: mdl-30863161
15.
Overexpression of malignant brain tumor domain containing protein 1 predicts a poor prognosis of prostate cancer.
Oncol Lett
; 17(5): 4640-4646, 2019 May.
Article
in English
| MEDLINE | ID: mdl-30944653
16.
The comparison of transurethral versus suprapubic catheter after robot-assisted radical prostatectomy: a systematic review and meta-analysis.
Transl Androl Urol
; 8(5): 476-488, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31807425
17.
Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Urol Oncol
; 36(8): 366.e1-366.e9, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29903461
Results
1 -
17
de 17
1
Next >
>>